Roger Blauvelt, MD
Orthopedic Surgery · Auburn, WANPI 1932187341
Payments from drug & device makers
What this record shows
18 manufacturers reported payments, led by Summit Surgical Corp. at 44.9% of the total. Reporting peaked in 2021 at $1,614 and has fallen 91.0% since, to $145 in 2025.
Across 39 payments — averaging $69.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Summit Surgical Corp.$1K
- Smith+Nephew$472
- Medartis Inc.$297
- Axogen$223
- Zimmer Biomet$126
- Zyla Life Sciences, Inc.$65
- plus $320 from 12 others
What the payments were for
- Food & beverage$1,46154%
- Education$1,26546%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Summit Surgical Corp. | 2 | $1,223 |
| Smith+Nephew | 8 | $472 |
| Medartis Inc. | 2 | $297 |
| Axogen | 4 | $223 |
| Zimmer Biomet | 4 | $126 |
| Zyla Life Sciences, Inc. | 1 | $65 |
| Zimvie Inc. | 2 | $52 |
| Pacira Therapeutics, Inc. | 2 | $47 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Orthofix Medical, Inc. | 2 | $28 |
| Merck | 2 | $27 |
| Linvatec Corporation | 1 | $22 |
| Innovation Technologies Inc | 1 | $22 |
| Heron Therapeutics, Inc. | 1 | $21 |
| Integra Lifesciences Corporation | 1 | $21 |
| Arteriocyte Medical Systems, Inc. | 1 | $17 |
| Amgen | 1 | $15 |
| Fidia Pharma USA Inc. | 2 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few orthopedic surgery providers in Washingtonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $117 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Auburn
- Brereton StraffordAuburn$2K
- Robert CarlsonAuburn$755
- Robert McKayOlympia$1K
- Joshua UrvaterEverett$0
- Jean WalshTacoma$0
- Anne McCormackSeattle$0
- Stacey DonionTacoma$0
- Greg NakamotoLynnwood$0
- John OslandBainbridge Island$0
- Richard BrownleeWenatchee$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.